NISA INVESTMENT ADVISORS, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,936
-78.2%
1,964
-66.3%
0.00%
Q2 2023$41,085
+171087.5%
5,836
+50.8%
0.00%
Q1 2023$24
+100.0%
3,871
+106.3%
0.00%
Q4 2022$12
-100.0%
1,876
-70.9%
0.00%
-100.0%
Q3 2022$60,000
-17.8%
6,438
-2.7%
0.00%0.0%
Q2 2022$73,000
+942.9%
6,614
+1459.9%
0.00%
Q1 2022$7,0000.0%4240.0%0.00%
Q4 2021$7,000
-65.0%
424
-48.3%
0.00%
Q3 2021$20,000
-88.0%
820
-87.1%
0.00%
-100.0%
Q2 2021$166,000
-17.8%
6,3690.0%0.00%0.0%
Q1 2021$202,000
-31.8%
6,3690.0%0.00%
-50.0%
Q4 2020$296,000
+55.0%
6,369
+10.0%
0.00%0.0%
Q3 2020$191,000
+11.7%
5,791
-7.3%
0.00%0.0%
Q2 2020$171,000
+557.7%
6,245
+625.3%
0.00%
Q1 2020$26,000
+36.8%
861
+22.8%
0.00%
Q4 2019$19,000
+46.2%
7010.0%0.00%
Q3 2019$13,000
-43.5%
701
-26.2%
0.00%
Q2 2019$23,000
+155.6%
9500.0%0.00%
Q1 2019$9,000
-18.2%
950
-20.8%
0.00%
Q4 2018$11,000
+83.3%
1,200
+135.3%
0.00%
Q3 2018$6,000
-33.3%
510
-27.1%
0.00%
Q2 2018$9,000
-25.0%
7000.0%0.00%
Q1 2018$12,0007000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders